Fertilist IVF Center
Menu

WHO WE ARE

For 30 years, we have been witnessing stories that begin with hope

The journey began in 1996 with the American Hospital IVF Center, and has since made rapid progress in the field of IVF with the participation of Koç University Hospital in 2014, the American Medical Center in 2015, and Anatolia American Hospitals in 2026. All our centers aim to provide patients with personalised IVF treatments through laboratories equipped with state-of-the-art technology and security systems, supported by experienced staff. To date, we have delivered the eagerly awaited news of a happy pregnancy to over 25,000 couples through IVF treatment.

Today, Fertilist IVF Center operates as a unified structure that has brought together the strengths of all these hospitals, serving patients with a team of physicians who closely follow scientific developments. Every treatment plan is developed in line with current scientific data, individual needs and ethical principles. Our aim is to support the journey to parenthood with reliable and sustainable success.

For 30 years, we have been witnessing stories that begin with hope

Mission

As Fertilist IVF Center, our mission is to provide world-class healthcare services in the field of IVF by combining scientific excellence, ethical responsibility and a compassionate approach to care. Recognising that the needs of every individual and couple are unique, we develop personalised treatment approaches based on current scientific evidence, advanced technology and multidisciplinary expertise. By prioritising transparency, trust and patient safety at every stage of the process, we aim to ensure that individuals experience this journey within a framework where they feel informed, supported and secure.

Vision

Guided by our scientific expertise, technological infrastructure and patient-centered approach, we strive to be a trusted and sustainable center of excellence in the field of IVF. Adopting an approach based on international quality standards, we embrace a philosophy that considers not only today's but also tomorrow's healthcare needs. With a focus on clinical excellence, commitment to ethical principles and continuous improvement, we aim to be a healthcare center trusted at both regional and international levels.

Core Values

A Patient-Centered Approach

A Patient-Centered Approach

We are aware that the IVF process is not just a clinical journey, but an emotional one as well. That is why we adopt a respectful, transparent and supportive approach at every stage, from the language we use to our care processes.

Scientific Responsibility

Scientific Responsibility

We shape all our practices in accordance with current scientific data, international guidelines and ethical principles. We keep a close eye on the ever-evolving field of medical knowledge and technology, and we never compromise on scientific accuracy.

A Personalised Approach to Treatment

A Personalised Approach to Treatment

Every individual's clinical condition, living circumstances and needs are unique. Therefore, we create personalised and holistic treatment plans rather than standard solutions. In every decision we make, we act in the best interests of the individual.

International Standards and Safety

International Standards and Safety

We adhere to international quality and patient safety standards, particularly JCI accreditation. We continuously monitor our clinical processes and prioritise the provision of reliable and sustainable healthcare services.

Milestones of Fertilist IVF Center

1996

American Hospital

The American Hospital IVF Center was established

2005

JCI Accreditation

JCI (Joint Commission International) accreditation was obtained

2010

8,000+ Births

The number of births exceeded 8,000

2014

Koç University Hospital

The IVF Center of Koç University Hospital was established

2015

American Medical Center

The IVF Center of the American Medical Center was established

2026

25,000+ Births

The number of births exceeded 25,000

25,000+

Successful Births

30

Years of Experience

85%+

Patient Satisfaction

Why Fertilist IVF Center?

Science-Backed Confidence

Science-Backed Confidence

Our treatment protocols are based on the latest scientific research and international guidelines, ensuring you receive evidence-based care with proven results.

Multidisciplinary Expert Team

Multidisciplinary Expert Team

Our experienced team of gynecologists, embryologists, andrologists, geneticists, and psychologists work together to provide comprehensive fertility care.

Advanced Technology & Laboratory

Advanced Technology & Laboratory

State-of-the-art IVF laboratories with cutting-edge equipment including time-lapse embryo monitoring, genetic screening, and advanced cryopreservation systems.

Personalized Treatment Plans

Personalized Treatment Plans

Every patient is unique. We create customized treatment protocols tailored to your specific needs, medical history, and fertility goals.

International Standards & Success

International Standards & Success

JCI accredited facility with success rates that meet or exceed international benchmarks, following ESHRE and ASRM guidelines.

Patient Experience & Communication

Patient Experience & Communication

Dedicated patient coordinators, multilingual support, and transparent communication ensure you feel informed and supported throughout your journey.

Accreditations and Certifications

ISO 9001 Certified Embryology Laboratory

Our laboratory holds the ISO 9001 certification, the international standard for quality management systems.

Joint Commission International (JCI) Accreditation

Our hospital is JCI accredited, representing the gold standard of healthcare quality worldwide.

Contact Us for More Information and Appointments

Our team of specialists will contact you as soon as possible to provide detailed information.

IVF Process

IVF treatment consists of four stages. These stages can be listed as follows: 1. Assessment of the couple, examination, diagnostic tests and determination of the treatment protocol: During the assessment of the couple, the patient's symptoms, medical history and family history are reviewed, and factors related to the cause of infertility are investigated. An ultrasound scan is performed to examine the structure of the reproductive organs, the uterus and the ovaries, and to identify any diseases or changes in neighbouring organs, investigating their relationship to infertility. If a problem is identified that hinders treatment or reduces the chances of success, steps are taken to resolve this issue first. During the ultrasound scan, an assessment of 'ovarian reserve' is carried out, which plays a significant role in selecting the treatment to be administered in the future and in determining the likelihood of treatment success. In addition, with a view to preparing for pregnancy, the presence of certain hormonal, metabolic and viral diseases that could adversely affect pregnancy, as well as the patient's immune status, is investigated. 2. Stimulation of the ovaries with medication: This constitutes the most important stage of the treatment. The treatment regimen to be administered during ovarian stimulation is determined based on the patient's age, the appearance of the ovaries on ultrasound, hormone test results, and, in patients who have previously undergone IVF, the response to treatment in the previous cycle. The physician's experience in determining this treatment directly influences the outcome. 3. Egg retrieval: Under anaesthesia, guided by transvaginal ultrasound, eggs are aspirated from the follicles containing the egg cells using a fine needle and removed from the body. 4. Embryo transfer: The best 1 or 2 embryos (fertilised eggs) are selected from those monitored in the laboratory and transferred into the uterus using a thin catheter. This procedure is similar to a routine examination and does not require anaesthesia.

The ideal time to start the egg stimulation process in IVF treatment is on the second or third day of the period. However, this is not an absolute requirement. Under certain specific conditions, ovarian stimulation medication can be started at any stage of the menstrual cycle.

Ovarian stimulation typically lasts approximately 8 to 14 days, although in some cases it may be shorter or longer. The growth of follicles that may contain eggs is monitored via ultrasound. Monitoring will require 4-5 visits to the IVF clinic during the course of treatment. In addition to ultrasound scans, hormone monitoring may also be carried out in some women. These hormones include oestrogen, progesterone and LH, and in some cases FSH. Once the follicles have reached the desired size, maturation injections (known as HCG or GnRH analogues) are administered to bring the eggs inside them to full maturity, and, barring certain special circumstances, the oocyte pick-up procedure is usually performed 34-38 hours later.

The oocyte pick-up (OPU) procedure is usually performed under local anaesthesia and takes approximately 15-30 minutes, depending on the number of follicles. If the ovarian response is limited and a small number of eggs are anticipated, the procedure may also be performed under local anaesthesia whilst the patient is awake. Following the procedure, you can return home after approximately 1-2 hours of observation and monitoring.

Once the oocyte pick-up has been completed, fertilisation with sperm takes place. The embryos are then monitored in the laboratory in special culture media for 3-5 days, or in some cases for 6-7 days. If there are any remaining high-quality embryos suitable for freezing after the transfer of those assessed in the laboratory and selected for transfer, these can be frozen and stored for transfer at a later date.

In Türkiye, the number of embryos that can be transferred is determined by regulations; for women under 35, it is limited to 1 embryo for the first 2 attempts, and for women over 35, it is limited to a maximum of 2 embryos. Under no circumstances is the transfer of more than two embryos permitted.

During the IVF treatment, ultrasound scans and blood tests are carried out during the egg stimulation phase to monitor egg development and adjust the dosage. On average, you will need to visit the hospital four or five times during the treatment process for these check-ups. As the time spent at the hospital during these check-ups is brief, they can be carried out without disrupting daily life or work routines.

Success Rates

The most up-to-date measure of success is the live birth rate of a single healthy baby per IVF cycle initiated. Multiple pregnancies are now considered high-risk, and transferring embryos one at a time wherever possible has become a global trend.

There are many variables that determine the chances of success in IVF, but the most important of these are the woman's age and ovarian reserve. In younger women with high ovarian reserve, the pregnancy rate (defined as the proportion of pregnancies resulting in live birth following the sequential transfer of all embryos obtained from a single egg retrieval) is higher. However, in women over the age of 40, this rate decreases, and by the age of 45, it drops to very low levels. Unfortunately, these results are not altered by supplements or 'rejuvenating' agents administered to the ovaries. AMH is one of the most reliable markers of ovarian reserve. Although a low AMH level does not necessarily mean pregnancy will or will not occur, it indicates that the number of oocytes picked up during the oocyte pick-up procedure will be low. Sperm quality is also a factor that directly affects embryo quality and the chances of pregnancy. In cases where there are very few sperm in the semen or where sperm must be retrieved from the testicles, embryo development is adversely affected.

Ovarian reserve is determined by an experienced physician performing a transvaginal ultrasound scan to assess the number of antral follicles present in the ovaries and their distribution. With advancing age, there will be a loss in the ovarian reserve; concurrently, there will be a reduction in ovarian volume and a decrease in the number of antral follicles. In addition to ultrasound, anti-Müllerian hormone (AMH) is the marker that best reflects ovarian reserve. Low AMH levels allow us to predict that the response from the ovaries during treatment will be poor, enabling us to tailor the treatment protocol accordingly.

In patients who have previously undergone unsuccessful IVF attempts, the most important factor determining the chances of success in the next treatment is the information regarding the ovarian response and embryo quality from the first treatment. When planning a new treatment, data from the previous treatment cycle is taken into account to plan how to obtain the healthiest and highest number of eggs from the ovaries. A history of low oocyte pick-up or poor-quality embryo development may be due to factors related to the patient, or it may be linked to the treatment protocol and medication doses used, as well as laboratory conditions. Other reasons for failure to achieve success include fibroids, polyps, blocked fallopian tubes, uterine malformations and intrauterine adhesions. Correcting these issues, where applicable, will increase the chances of pregnancy. Additional tests and assessments, such as investigations into coagulation disorders (congenital or acquired) and immune function, are not routinely recommended. The cause-and-effect relationship for both is unclear.

Various supportive medications, primarily the hormone progesterone, are used to support the embryo's implantation in the uterus following embryo transfer. The use of medications without scientific evidence (such as aspirin, blood thinners, agents that inhibit uterine contractions, immunosuppressive drugs, etc.) or strict bed rest will not increase the embryo's chances of implantation and will only cause unnecessary anxiety and expense.

Artificial Intelligence Applications

It is a fact that artificial intelligence technologies are developing rapidly and are making workflows more efficient in many fields. It is highly likely that it will find applications in IVF treatments, particularly in laboratory procedures. However, as of January 2026, there is no artificial intelligence application that delivers better results than experienced embryologists.

Artificial intelligence is increasingly being used in IVF laboratories for embryo selection. Time-lapse embryo monitoring systems and AI-based algorithms help identify the embryo with the highest implantation potential by analysing their division rates and developmental patterns. Although this technology is still in its developmental stage, it is difficult to state with certainty that it provides more objective and consistent results compared to standard evaluations.

View All Questions